0000950170-24-071518.txt : 20240610
0000950170-24-071518.hdr.sgml : 20240610
20240610193112
ACCESSION NUMBER: 0000950170-24-071518
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240610
DATE AS OF CHANGE: 20240610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zurbay Donald
CENTRAL INDEX KEY: 0001341608
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40587
FILM NUMBER: 241034304
MAIL ADDRESS:
STREET 1: C/O ST. JUDE MEDICAL, INC.
STREET 2: ONE ST JUDE MEDICAL DRIVE
CITY: ST. PAUL
STATE: MN
ZIP: 55117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sight Sciences, Inc.
CENTRAL INDEX KEY: 0001531177
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 800625749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4040 CAMPBELL AVE,
STREET 2: SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: (415) 889-0550
MAIL ADDRESS:
STREET 1: 4040 CAMPBELL AVE,
STREET 2: SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
ownership.xml
4
X0508
4
2024-06-06
0001531177
Sight Sciences, Inc.
SGHT
0001341608
Zurbay Donald
C/O SIGHT SCIENCES, INC.
4040 CAMPBELL AVE., SUITE 100
MENLO PARK
CA
94025
true
false
false
false
false
Common Stock
2024-06-06
4
A
false
17366
0.00
A
117460
D
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the closing price of the Common Stock on the grant date, June 6, 2024. The RSUs vest on the earlier of June 6, 2025 and the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
Includes (i) 15,094 shares of Common Stock, (ii) 17,366 RSUs, which are subject to vesting as reported herein, and (iii) 85,000 shares of Common Stock, which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of June 6, 2024.
/s/ Jeremy Hayden, Attorney-in-Fact for Donald Zurbay
2024-06-10